Molecular features, regulation, and function of monocarboxylate transporters

Implications for drug delivery

Bradley E. Enerson, Lester R Drewes

Research output: Contribution to journalShort survey

148 Citations (Scopus)

Abstract

The diffusion of monocarboxylates such as lactate and pyruvate across the plasma membrane of mammalian cells is facilitated by a family of integral membrane transport proteins, the monocarboxylate transporters (MCTs). Currently, at least eight unique members of the MCT family have been discovered and orthologs to each have been identified in a variety of species. Four MCTs (MCT1-MCT4) have been functionally characterized. Each isoform possesses unique biochemical properties such as kinetic constants and sensitivity to known MCT inhibitors. Several fold changes in the expression of MCTs may be evoked by altered physiological conditions, yet the molecular mechanisms underlying the regulation of MCTs are poorly understood. Post-translational regulation of MCT1 and MCT4 occurs, in part, by interaction with CD147, an accessory protein that is necessary for trafficking, localization, and functional expression of these transporters. Because of the physiological importance of monocarboxylates to the overall maintenance of metabolic homeostasis, the function of MCTs is significant to several pathologies that occur with disease, such as ischemic stroke and cancer. Finally, the expression of MCT1 in the epithelium of the small intestine and colon and in the blood-brain barrier may provide routes for the intestinal and blood to brain transfer of carboxylated pharmaceutical agents and other exogenous monocarboxylates.

Original languageEnglish (US)
Pages (from-to)1531-1544
Number of pages14
JournalJournal of Pharmaceutical Sciences
Volume92
Issue number8
DOIs
StatePublished - Aug 1 2003

Fingerprint

Membrane Transport Proteins
Blood-Brain Barrier
Pyruvic Acid
Pharmaceutical Preparations
Small Intestine
Lactic Acid
Protein Isoforms
Membrane Proteins
Colon
Homeostasis
Epithelium
Stroke
Maintenance
Cell Membrane
Pathology
Brain
Neoplasms
Proteins

Keywords

  • Blood-brain barrier
  • Epithelium
  • Lactate
  • Monocarboxylate
  • Transport

Cite this

Molecular features, regulation, and function of monocarboxylate transporters : Implications for drug delivery. / Enerson, Bradley E.; Drewes, Lester R.

In: Journal of Pharmaceutical Sciences, Vol. 92, No. 8, 01.08.2003, p. 1531-1544.

Research output: Contribution to journalShort survey

@article{feea4ad116964eb1bcee33a57227dbc1,
title = "Molecular features, regulation, and function of monocarboxylate transporters: Implications for drug delivery",
abstract = "The diffusion of monocarboxylates such as lactate and pyruvate across the plasma membrane of mammalian cells is facilitated by a family of integral membrane transport proteins, the monocarboxylate transporters (MCTs). Currently, at least eight unique members of the MCT family have been discovered and orthologs to each have been identified in a variety of species. Four MCTs (MCT1-MCT4) have been functionally characterized. Each isoform possesses unique biochemical properties such as kinetic constants and sensitivity to known MCT inhibitors. Several fold changes in the expression of MCTs may be evoked by altered physiological conditions, yet the molecular mechanisms underlying the regulation of MCTs are poorly understood. Post-translational regulation of MCT1 and MCT4 occurs, in part, by interaction with CD147, an accessory protein that is necessary for trafficking, localization, and functional expression of these transporters. Because of the physiological importance of monocarboxylates to the overall maintenance of metabolic homeostasis, the function of MCTs is significant to several pathologies that occur with disease, such as ischemic stroke and cancer. Finally, the expression of MCT1 in the epithelium of the small intestine and colon and in the blood-brain barrier may provide routes for the intestinal and blood to brain transfer of carboxylated pharmaceutical agents and other exogenous monocarboxylates.",
keywords = "Blood-brain barrier, Epithelium, Lactate, Monocarboxylate, Transport",
author = "Enerson, {Bradley E.} and Drewes, {Lester R}",
year = "2003",
month = "8",
day = "1",
doi = "10.1002/jps.10389",
language = "English (US)",
volume = "92",
pages = "1531--1544",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

TY - JOUR

T1 - Molecular features, regulation, and function of monocarboxylate transporters

T2 - Implications for drug delivery

AU - Enerson, Bradley E.

AU - Drewes, Lester R

PY - 2003/8/1

Y1 - 2003/8/1

N2 - The diffusion of monocarboxylates such as lactate and pyruvate across the plasma membrane of mammalian cells is facilitated by a family of integral membrane transport proteins, the monocarboxylate transporters (MCTs). Currently, at least eight unique members of the MCT family have been discovered and orthologs to each have been identified in a variety of species. Four MCTs (MCT1-MCT4) have been functionally characterized. Each isoform possesses unique biochemical properties such as kinetic constants and sensitivity to known MCT inhibitors. Several fold changes in the expression of MCTs may be evoked by altered physiological conditions, yet the molecular mechanisms underlying the regulation of MCTs are poorly understood. Post-translational regulation of MCT1 and MCT4 occurs, in part, by interaction with CD147, an accessory protein that is necessary for trafficking, localization, and functional expression of these transporters. Because of the physiological importance of monocarboxylates to the overall maintenance of metabolic homeostasis, the function of MCTs is significant to several pathologies that occur with disease, such as ischemic stroke and cancer. Finally, the expression of MCT1 in the epithelium of the small intestine and colon and in the blood-brain barrier may provide routes for the intestinal and blood to brain transfer of carboxylated pharmaceutical agents and other exogenous monocarboxylates.

AB - The diffusion of monocarboxylates such as lactate and pyruvate across the plasma membrane of mammalian cells is facilitated by a family of integral membrane transport proteins, the monocarboxylate transporters (MCTs). Currently, at least eight unique members of the MCT family have been discovered and orthologs to each have been identified in a variety of species. Four MCTs (MCT1-MCT4) have been functionally characterized. Each isoform possesses unique biochemical properties such as kinetic constants and sensitivity to known MCT inhibitors. Several fold changes in the expression of MCTs may be evoked by altered physiological conditions, yet the molecular mechanisms underlying the regulation of MCTs are poorly understood. Post-translational regulation of MCT1 and MCT4 occurs, in part, by interaction with CD147, an accessory protein that is necessary for trafficking, localization, and functional expression of these transporters. Because of the physiological importance of monocarboxylates to the overall maintenance of metabolic homeostasis, the function of MCTs is significant to several pathologies that occur with disease, such as ischemic stroke and cancer. Finally, the expression of MCT1 in the epithelium of the small intestine and colon and in the blood-brain barrier may provide routes for the intestinal and blood to brain transfer of carboxylated pharmaceutical agents and other exogenous monocarboxylates.

KW - Blood-brain barrier

KW - Epithelium

KW - Lactate

KW - Monocarboxylate

KW - Transport

UR - http://www.scopus.com/inward/record.url?scp=0043212093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0043212093&partnerID=8YFLogxK

U2 - 10.1002/jps.10389

DO - 10.1002/jps.10389

M3 - Short survey

VL - 92

SP - 1531

EP - 1544

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 8

ER -